Inotiv, Inc.
NOTVNASDAQHealthcareDiagnostics & Research

About Inotiv

Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the company’s BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.

Company Information

CEORobert Leasure
Founded1974
IPO DateNovember 24, 1997
Employees2,046
CountryUnited States
Fiscal YearOctober - September

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Phone765 463 4527
Address
2701 Kent Avenue West Lafayette, Indiana 47906 United States

Corporate Identifiers

CIK0000720154
CUSIP45783Q100
ISINUS45783Q1004
EIN35-1345024
SIC8731

Leadership Team & Key Executives

Robert W. Leasure Jr.
President, Chief Executive Officer and Director
Beth A. Taylor CPA
Executive Vice President and Chief Financial Officer
Dr. John E. Sagartz D.V.M., DiplomateACVP, Ph.D.
Chief Strategy Officer and Director
Brennan Freeman
Vice President of Finance, Principal Accounting Officer and Corporate Controller
Andrea Castetter
Executive Vice President of General Counsel and Corporate Secretary and Chief Compliance Office
Jeffrey Arthur Krupp
Chief Human Resources Officer
John Gregory Beattie DSA
Chief Operating Officer of DSA
Dr. Adrian Hardy Ph.D.
Chief Commercial Officer
Lizanne Muller
Group President of RMS